Detalhe da pesquisa
1.
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
Br J Haematol
; 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38429869
2.
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
Am J Hematol
; 97(8): 1055-1064, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35472249
3.
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.
Future Oncol
; 18(38): 4161-4170, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36524980
4.
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
Am J Hematol
; 96(4): 404-417, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33264445
5.
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel.
Acta Haematol
; 144(4): 418-426, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33789275